Nordic Share & Connect: Transforming Health with Novo Nordisk Pharma Japan & Pres. & Rep. Dir. Kasper Bødker Mejlvang

Join DCCJ, FCCJ, ISCCJ, NCCJ, and SCCJ for another exciting Nordic Share & Connect event. You'll have the opportunity to learn about Novo Nordisk Pharma Japan and hear insights from the team on the company’s future direction in Japan and internationally.

On Wednesday, March 19th, at the Novo Nordisk Pharma Japan’s HQ office in Tokyo,  participants will have the exciting opportunity to learn about the company and its new mid-term strategy. Kasper Bødker Mejlvang, President & Representative Director and a director on the DCCJ board, will also share his insights on the company’s initiatives and the latest industry trends.

About Novo Nordisk Pharma

Founded in Denmark in 1923, Novo Nordisk is a global leader in healthcare, focusing on the treatment of diabetes, obesity, rare endocrine disorders, and blood disorders. With almost a century of innovation, the company continues to lead in research and development, expanding into new therapeutic areas. Novo Nordisk is committed to sustainable growth, emphasizing disease prevention, improving access to treatment, and environmental responsibility.

Novo Nordisk's Japanese subsidiary was established in 1980 and is headquartered in Tokyo. With over 1,100 employees and 53 sales offices across Japan, the company is committed to expanding its business, addressing social challenges, and improving patient outcomes across various health sectors.

If you're involved in business in Japan, especially in health or pharmaceuticals, this is an event you won’t want to miss.

About Nordic Share & Connect

An event series created and hosted by the Nordic Chambers, including DCCJ, FCCJ, ISCCJ, NCCJ, and SCCJ. The initiative opens the doors of prominent businesses in the Nordic Business Community in Japan to share insights on their industry, business practices, and current market trends, fostering networking and collaboration within the Nordic-Japanese community.

Agenda

17:00 Doors open

17:30 Company Introduction

17:40 Presentation

18:10 Q&A

18:30 Networking

19:15 End

Event Details

Date: Wednesday, March 19th, 2025

Time: 17:30-19:15

Venue: Novo Nordisk Japan HQ office in Tokyo

Meiji Yasuda Life Building 13F, 2 Chome-1-1 Marunouchi, Chiyoda City, Tokyo 100-0005

Organized by: DCCJ and Nordic Net•Works (Nordic Chambers of Commerce in Japan)

*Important Access Reminder: The Novo Nordisk office is located on the 13th floor of the Meiji Yasuda Life Building. All participants must first check in on the 3rd floor, where staff will then guide you to the 13th floor.

Admission

DCCJ/FCCJ/ISCCJ/NCCJ/SCCJ Member: Free

*The deadline to RSVP is Thursday, March 13th, 2025 at 16:00.

*This is a Nordic Net•Works Members-only event.

*Light refreshments will be served.

About the Speaker

Kasper Bødker Mejlvang (KSME)

Novo Nordisk Pharma, SVP Region Japan

Kasper joined Novo Nordisk in 2002 and has worked in various leadership roles across several geographies. Kasper held roles in different part of the value chain such as Global P&O, Product Supply, Research & Development, and International Operations. He held several leadership roles in manufacturing heading up Insulin API manufacturing, Product Supply Global Support followed by heading up the production site in Chartres, France leading a large turnaround of the site and growing it to more than 1,100 FTEs. Prior to his relocation to Japan, he was the General Manager of the Danish affiliate. Both in his current and previous roles, Kasper has played an active role in the health care system as he was the Vice Chair of the Board of Directors of the Danish pharmaceutical trade association as well as he is currently the Vice Chair of the Board of Directors of the European Federation of Pharmaceutical Industries and Associations Japan. Kasper was born in 1977 and holds an MSc Management, MSc in Psychology and an Executive MBA degree.